Artificial Intelligence (AI)

Photo
11.12.2024 • NewsStrategy

Navigating the Future of Chemical Distribution

In 2024, the chemical distribution industry is at a pivotal moment, navigating both challenges and new opportunities. As distributors grapple with a landscape shaped by shifting global trade routes, demand constraints, and digital disruption, their roles are evolving far beyond traditional bulk breaking.

Photo
11.11.2024 • TopicsDigitalization

Artificial Intelligence – a Revolution for Innovation?

Artificial intelligence (AI) has made groundbreaking progress in recent years, particularly through innovations in machine learning and neural networks. These developments are largely driven by deep learning technologies, which enable the recognition of complex data patterns and the achievement of human-like performance in areas such as speech recognition, image processing, and decision-making.

Photo
13.09.2024 • News

Egrobots – New Technologies for a more Sustainable Agriculture

Egrobots, a start-up from Egypt, developed a solution for efficient farm monitoring and management using AI and robotics. Their innovation includes an autonomous robot, that roams around the farm, scanning the plants on a leaf-level with high resolution and an AI that analyses this data.

Photo
19.03.2024 • NewsStrategy

Generative AI in Chromatographic Analysis

Generative AI can impact the field of chromatography in various innovative ways. However, great care needs to be taken to validate any use of this emerging technology from a technical, quality and regulatory perspective.

Photo
12.12.2023 • NewsInnovation

Accelerate Chemical and Material Development

Process manufacturing companies waste almost $100 billion globally every year while formulating novel materials and chemicals due to the trial-and-error approach to R&D and the lack of tools to leverage the experimental data in real-time.

Photo
11.12.2023 • NewsInnovation

Making Lab Automation Actually Work

Manual experiment monitoring and data capture is still the status quo in most biotech and pharma labs, compromising efficiency and project timescales. But there is a better way.

Photo
11.12.2023 • NewsInnovation

Accelerating Chemicals Innovation

The Spanish computational chemistry start-up Nextmol (Bytelab Solutions), a spin-off from the Barcelona Supercomputing Centre, offers a software-as-a-service (SaaS) platform that accelerates research and innovation in sustainable specialty chemicals through “in silico” experiments using molecular modeling and artificial intelligence (AI).

Photo
24.10.2023 • News

CPHI Annual Report on Pharmaceutical Industry

The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing questions, with their answers informing the industry landscape for the next year, spanning all major pharma markets.

Photo
24.10.2023 • News

AstraZeneca Granted Global Starmap AI License for Nanoform

Nanoform, a nanoparticle medical technology company, has awarded AstraZeneca a global online STARMAP license. STARMAP is an AI-based digital rendition of CESS technology, facilitating in-silico experiments for selecting molecules to be nanoformed. This license enables AstraZeneca to screen molecules during the entire drug development process.

Photo
02.10.2023 • News

AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials

AI and analytics software company SAS is collaborating with global biopharmaceutical company AstraZeneca to increase efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.

Photo
16.01.2023 • News

BioNTech to Acquire all of InstaDeep

As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to acquire all of London-based artificial intelligence specialist InstaDeep.

Photo
18.10.2022 • TopicsTechnology

AI Maturity Model for GxP Application

Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP-regulated areas also want to use AI in a beneficial way, but only a small fraction of companies follows a systematic approach for the digitalization of their operations and validation. However, the assurance of integrity and quality of outputs via computerized system validation is essential for applications in GxP environments.

Photo
17.09.2020 • TopicsInnovation

Accelerated Drug Discovery

In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.

Photo
15.06.2020 • TopicsInnovation

Creating the AI-Powered Future of Chemistry

Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.

1 more articles

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.